Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2002 Apr;11(2):69–73. doi: 10.1080/09629350220131908

Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation.

Johannes Graulich 1, Joseph Sonntag 1, Monika Marcinkowski 1, Karl Bauer 1, Hans Kössel 1, Christoph Bührer 1, Michael Obladen 1, Hans T Versmold 1
PMCID: PMC1781648  PMID: 12061426

Abstract

Complment activation during extracorporeal membrane oxygenation (ECMO) in newborns can be caused by both the underlying disease processes and by blood contact with the ECMO circuit. We investigated the relative importance of these mechanisms by measuring C3a, C5a and sC5b-9 before, during and after neonatal ECMO in six consecutive newborn patients using enzyme-linked immunoassay. In addition complement activation during in vitro ECMO with repeated flow of the same blood volume was measured using blood from healthy adult donors. C3a increased significantly in vivo after 1 h (from 1035+/-193 to 1865+/-419 microg/l) and in vitro ECMO (from 314+/-75 to 1962+/-1062 microg/l). C5a increased during ECMO without significant differences between in vivo and in vitro activation. In neonatal patients, sC5b-9 rose faster than in vitro, but the rapid increase was also significant for in vitro experiments (in vivo: from 328+/-63 to 1623+/-387 microg/l after 2 h; and in vitro: from 78+/-32 to 453+/-179 microg/l after 8 h). After this initial peak at 1-2 h, complement activation decreased gradually until 2-3 days after the initiation of ECMO. We conclude that in newborns the rapid activation of the complement system after the start of ECMO is predominantly caused by contact with artificial surfaces rather than the patient's underlying disease.

Full Text

The Full Text of this article is available as a PDF (155.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson H. L., 3rd, Coran A. G., Drongowski R. A., Ha H. J., Bartlett R. H. Extracellular fluid and total body water changes in neonates undergoing extracorporeal membrane oxygenation. J Pediatr Surg. 1992 Aug;27(8):1003–1008. doi: 10.1016/0022-3468(92)90547-k. [DOI] [PubMed] [Google Scholar]
  2. Bennett C. C., Johnson A., Field D. J., Elbourne D., UK Collaborative ECMO Trial Group UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet. 2001 Apr 7;357(9262):1094–1096. doi: 10.1016/S0140-6736(00)04310-5. [DOI] [PubMed] [Google Scholar]
  3. Bührer C., Luxenburger U., Metze B., Kattner E., Henze G., Dudenhausen J. W., Obladen M. Diminished cord blood lymphocyte L-selectin expression in neonatal bacterial infection. Eur J Pediatr. 1993 Jun;152(6):519–522. doi: 10.1007/BF01955064. [DOI] [PubMed] [Google Scholar]
  4. Fortenberry J. D., Bhardwaj V., Niemer P., Cornish J. D., Wright J. A., Bland L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr. 1996 May;128(5 Pt 1):670–678. doi: 10.1016/s0022-3476(96)80133-8. [DOI] [PubMed] [Google Scholar]
  5. Graulich J., Walzog B., Marcinkowski M., Bauer K., Kössel H., Fuhrmann G., Bührer C., Gaehtgens P., Versmold H. T. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO). Pediatr Res. 2000 Nov;48(5):679–684. doi: 10.1203/00006450-200011000-00021. [DOI] [PubMed] [Google Scholar]
  6. Hetland G., Moen O., Bergh K., Högäsen K., Hack C. E., Mollnes T. E., Fosse E. Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. Ann Thorac Surg. 1997 Apr;63(4):1076–1080. doi: 10.1016/s0003-4975(96)01255-6. [DOI] [PubMed] [Google Scholar]
  7. Hirthler M., Simoni J., Dickson M. Elevated levels of endotoxin, oxygen-derived free radicals, and cytokines during extracorporeal membrane oxygenation. J Pediatr Surg. 1992 Sep;27(9):1199–1202. doi: 10.1016/0022-3468(92)90787-8. [DOI] [PubMed] [Google Scholar]
  8. Hocker J. R., Wellhausen S. R., Ward R. A., Simpson P. M., Cook L. N. Effect of extracorporeal membrane oxygenation on leukocyte function in neonates. Artif Organs. 1991 Feb;15(1):23–28. doi: 10.1111/j.1525-1594.1991.tb00755.x. [DOI] [PubMed] [Google Scholar]
  9. Ishino K., Weng Y., Alexi-Meskishvili V., Loebe M., Uhlemann F., Lange P. E., Hetzer R. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in children. Artif Organs. 1996 Jun;20(6):728–732. [PubMed] [Google Scholar]
  10. Kelly R. E., Jr, Phillips J. D., Foglia R. P., Bjerke H. S., Barcliff L. T., Petrus L., Hall T. R. Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg. 1991 Sep;26(9):1016–1022. doi: 10.1016/0022-3468(91)90665-g. [DOI] [PubMed] [Google Scholar]
  11. Mollnes T. E., Videm V., Götze O., Harboe M., Oppermann M. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. Ann Thorac Surg. 1991 Jul;52(1):92–97. doi: 10.1016/0003-4975(91)91426-v. [DOI] [PubMed] [Google Scholar]
  12. Plötz F. B., van Oeveren W., Bartlett R. H., Wildevuur C. R. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg. 1993 May;105(5):823–832. [PubMed] [Google Scholar]
  13. Sonntag J., Brandenburg U., Polzehl D., Strauss E., Vogel M., Dudenhausen J. W., Obladen M. Complement system in healthy term newborns: reference values in umbilical cord blood. Pediatr Dev Pathol. 1998 Mar-Apr;1(2):131–135. doi: 10.1007/s100249900016. [DOI] [PubMed] [Google Scholar]
  14. Sonntag J., Dähnert I., Stiller B., Hetzer R., Lange P. E. Complement and contact activation during cardiovascular operations in infants. Ann Thorac Surg. 1998 Feb;65(2):525–531. doi: 10.1016/s0003-4975(97)01340-4. [DOI] [PubMed] [Google Scholar]
  15. Sonntag J., Emeis M., Vornwald A., Strauss E., Maier R. F. Complement activation during plasma production depends on the apheresis technique. Transfus Med. 1998 Sep;8(3):205–208. doi: 10.1046/j.1365-3148.1998.00150.x. [DOI] [PubMed] [Google Scholar]
  16. Tofukuji M., Stahl G. L., Agah A., Metais C., Simons M., Sellke F. W. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. J Thorac Cardiovasc Surg. 1998 Dec;116(6):1060–1068. doi: 10.1016/S0022-5223(98)70059-5. [DOI] [PubMed] [Google Scholar]
  17. Urlesberger B., Zobel G., Zenz W., Kuttnig-Haim M., Maurer U., Reiterer F., Riccabona M., Dacar D., Gallisti S., Leschnik B. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr. 1996 Aug;129(2):264–268. doi: 10.1016/s0022-3476(96)70252-4. [DOI] [PubMed] [Google Scholar]
  18. Vallhonrat H., Swinford R. D., Ingelfinger J. R., Williams W. W., Ryan D. P., Tolkoff-Rubin N., Cosimi A. B., Pascual M. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation. ASAIO J. 1999 Jan-Feb;45(1):113–114. doi: 10.1097/00002480-199901000-00025. [DOI] [PubMed] [Google Scholar]
  19. Wagner M. H., Sonntag J., Strauss E., Obladen M. Complement and contact activation related to surfactant response in respiratory distress syndrome. Pediatr Res. 1999 Jan;45(1):14–18. doi: 10.1203/00006450-199901000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES